Screening compound: InChI=1S/C20H13F3N2O2S/c21-14-4-7-19-13(8-14)10-20(24-19)12-2-1-3-15(9-12)25-28(26,27)16-5-6-17(22)18(23)11-16/h1-11,24-25H

Screening compound: InChI=1S/C20H13F3N2O2S/c21-14-4-7-19-13(8-14)10-20(24-19)12-2-1-3-15(9-12)25-28(26,27)16-5-6-17(22)18(23)11-16/h1-11,24-25H
Screening compound: InChI=1S/C20H13F3N2O2S/c21-14-4-7-19-13(8-14)10-20(24-19)12-2-1-3-15(9-12)25-28(26,27)16-5-6-17(22)18(23)11-16/h1-11,24-25H alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C20H13F3N2O2S/c21-14-4-7-19-13(8-14)10-20(24-19)12-2-1-3-15(9-12)25-28(26,27)16-5-6-17(22)18(23)11-16/h1-11,24-25H

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L007-0244

Molecular Formula

C20H13F3N2O2S (C20 H13 F3 N2 O2 S)

Compound Name

3,4-difluoro-N-[3-(5-fluoro-1H-indol-2-yl)phenyl]benzene-1-sulfonamide

IUPAC name

34-difluoro-N-[3-(5-fluoro-1H-indol-2-yl)phenyl]benzene-1-sulfonamide

SMILES

O=S(c(cc1)cc(F)c1F)(Nc1cc(-c2cc(cc(cc3)F)c3[nH]2)ccc1)=O

InChI

InChI=1S/C20H13F3N2O2S/c21-14-4-7-19-13(8-14)10-20(24-19)12-2-1-3-15(9-12)25-28(26,27)16-5-6-17(22)18(23)11-16/h1-11,24-25H

InChI Key

ZNYBMOKPVYWEHP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15116348

InChI=1S/C20H13F3N2O2S/c21-14-4-7-19-13(8-14)10-20(24-19)12-2-1-3-15(9-12)25-28(26,27)16-5-6-17(22)18(23)11-16/h1-11,24-25H in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

Autophagy-Targeted Library (4564 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Infections
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with InChI=1S/C20H13F3N2O2S/c21-14-4-7-19-13(8-14)10-20(24-19)12-2-1-3-15(9-12)25-28(26,27)16-5-6-17(22)18(23)11-16/h1-11,24-25H chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C20H13F3N2O2S/c21-14-4-7-19-13(8-14)10-20(24-19)12-2-1-3-15(9-12)25-28(26,27)16-5-6-17(22)18(23)11-16/h1-11,24-25H?
Check Price and Availability of InChI=1S/C20H13F3N2O2S/c21-14-4-7-19-13(8-14)10-20(24-19)12-2-1-3-15(9-12)25-28(26,27)16-5-6-17(22)18(23)11-16/h1-11,24-25H, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C20H13F3N2O2S/c21-14-4-7-19-13(8-14)10-20(24-19)12-2-1-3-15(9-12)25-28(26,27)16-5-6-17(22)18(23)11-16/h1-11,24-25H you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C20H13F3N2O2S/c21-14-4-7-19-13(8-14)10-20(24-19)12-2-1-3-15(9-12)25-28(26,27)16-5-6-17(22)18(23)11-16/h1-11,24-25H
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C20H13F3N2O2S/c21-14-4-7-19-13(8-14)10-20(24-19)12-2-1-3-15(9-12)25-28(26,27)16-5-6-17(22)18(23)11-16/h1-11,24-25H
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C20H13F3N2O2S/c21-14-4-7-19-13(8-14)10-20(24-19)12-2-1-3-15(9-12)25-28(26,27)16-5-6-17(22)18(23)11-16/h1-11,24-25H available by request